Human breast milk fortification with human milk fortifier vs preterm infant formula: A systematic review and meta-analysis
Journal of Neonatal-Perinatal Medicine · 2026-01 · 19 (1) · 10-21
DOI: 10.1177/19345798251350987 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neonatal-Perinatal Medicine, online erschienen am 19.06.2025. Verfasst von Ni Nyoman Berlian Aryadevi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. Hauptthemen laut MEDLINE: Milk, Human, Infant, Premature, Food, Fortified, Infant Formula. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Background
The limited availability and high cost of human milk fortifier (HMF) in developing countries represent significant challenges. Preterm formula (PTF) fortification of breast milk is a potential alternative, but its safety and impact on growth are still uncertain. This study compares the safety and effect of breast milk fortification with PTF versus HMF on growth velocity in very low birth weight preterm infants.
Methods
A thorough literature search was conducted in the PubMed, Scopus, Google Scholar, ClinicalTrials.gov , and Europe PMC databases up to March 24, 2024. Relevant randomized controlled trials (RCTs) studying fortifying breast milk with PTF or HMF were identified and their quality assessed using the Cochrane Risk of Bias 2 tool. Statistical analysis was performed in Review Manager Web, and certainty of evidence was assessed with GRADE.
Results
Six RCTs were included, of which one exhibited low bias risk, three had moderate concerns, and two were classed as high risk. The six RCTs, involving 434 preterm infants, revealed no significant differences in the gain of weight (SMD 0, 95% CI −0.19 to 0.19), length (MD −0.01 cm/wk, 95% CI −0.06 to 0.05), or head circumference (MD −0.01 cm/wk, 95% CI −0.06 to 0.04) between PTF and HMF. There were comparable risks of morbidities.
Conclusion
Very low certainty evidence suggests that breast milk fortification with PTF may be a safe alternative to HMF, with similar safety profiles and effects on growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
- Department of Child Health, Faculty of Medicine, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia.
- Universitas Indonesia Hospital, Depok, Indonesia.
ORCID-Profile: Ni Nyoman Berlian Aryadevi, Rosita Saumi Imanta Putri, Putri Maharani Tristanita Marsubrin
Zitieren
APA
Aryadevi, N. N. B., Putri, R. S. I., & Marsubrin, P. M. T. (2026). Human breast milk fortification with human milk fortifier vs preterm infant formula: A systematic review and meta-analysis. Journal of Neonatal-Perinatal Medicine, 19(1), 10-21. https://doi.org/10.1177/19345798251350987
Vancouver
Aryadevi NNB, Putri RSI, Marsubrin PMT. Human breast milk fortification with human milk fortifier vs preterm infant formula: A systematic review and meta-analysis. Journal of Neonatal-Perinatal Medicine. 2026;19(1):10-21. doi:10.1177/19345798251350987
BibTeX
@article{Aryadevi2026,
author = {Aryadevi, Ni Nyoman Berlian and Putri, Rosita Saumi Imanta and Marsubrin, Putri Maharani Tristanita},
title = {Human breast milk fortification with human milk fortifier vs preterm infant formula: A systematic review and meta-analysis},
journal = {Journal of Neonatal-Perinatal Medicine},
year = {2026},
volume = {19},
number = {1},
pages = {10--21},
doi = {10.1177/19345798251350987}
}
EUVIMED